Despite operating as essential services during the pandemic, VITAS and Roto-Rooter experienced significant challenges. However, April saw the most difficulties, and operations gradually improved throughout Q2. VITAS' net revenue increased by 4.7%, with admissions declining by 3.8%. Roto-Rooter's revenue increased by 8.6%, with a decline in commercial services offset by growth in residential services. Both segments maintained profitability, with Roto-Rooter's adjusted EBITDA margin increasing to 26.8%. Chemed estimates 2020 revenue growth for VITAS of 5% to 7%, Average Daily Census expansion of 2% to 4%, and an adjusted EBITDA margin of 19% to 20%. Roto-Rooter's full-year revenue growth is projected to be 9% to 10%, with an adjusted EBITDA margin of 23% to 25%. Chemed's full-year adjusted earnings per diluted share are estimated at $16.20 to $16.40, excluding non-cash expenses, tax benefits, litigation costs, and CARES Act funds used for lost revenue. The company prioritized employee safety, ensured supply chain stability, and continued to provide high-quality care and services, adhering to government regulations and adapting to the challenges posed by the pandemic.